Research We Have Funded
Through the generosity of our donors, the BrightFocus Foundation is proud to have committed more than $131.5 million dollars to fund research on diseases that affect mind and sight, as of July 1, 2013.
The BrightFocus research portfolio is characterized by prominent and promising scientists who have dedicated their careers to making lives stronger, healthier, and happier. BrightFocus sincerely appreciates our donors, who allow us to continue our long tradition of support for innovative and catalytic research.
Alzheimer’s Disease Research Grants
Since the Alzheimer's Disease Research (ADR) program began, BrightFocus has awarded more than $82.5 million to support promising Alzheimer's investigations in fields ranging from molecular biology to epidemiology. ADR is currently supporting 58 outstanding biomedical research projects. BrightFocus is honored to have played a role in supporting the research of two Nobel Prize winners: Dr. Stanley Prusiner and Dr. Paul Greengard. Learn more about ADR sponsored research.
Macular Degeneration Research Grants
The Macular Degeneration Research Program (MDR) is BrightFocus’ newest program. BrightFocus has awarded more than $13.9 million to support basic research into the causes and potential treatments of this disease. MDR is currently supporting 24 biomedical research projects. Learn more about this research.
National Glaucoma Research Grants
BrightFocus has awarded more than $22.6 million to support basic research into the causes and potential treatments of glaucoma. National Glaucoma Research is currently supporting 31 biomedical research projects. Learn more about this research.
Last Review: 07/01/13